CDC advisory committee unanimously recommends Pfizer’s pediatric COVID-19 vaccine

The Centers for Disease Control and Prevention’s independent Advisory Committee on Immunization Practices today recommended Pfizer’s COVID-19 vaccine be administered for children ages five through 11. The 14-0 vote paves the way for the first doses to be administered to that age group, pending approval by CDC Director Rochelle Walensky, M.D. Across its deliberations, the committee urged thorough, clear communications with families of potential-but-rare side effects, including myocarditis, with information on symptoms and where to seek medical care.
Related News Articles
Headline
Most health insurers must cover the updated COVID-19 vaccines from Pfizer and Moderna without cost sharing effective Sept. 11, when the Food and Drug…
Headline
AHA today participated in a Centers for Disease Control and Prevention Fall Immunization Kick-off Event for partner organizations, which focused on vaccinating…
Headline
The Food and Drug Administration’s independent Nonprescription Drugs Advisory Committee Sept. 12 by unanimous vote declared oral phenylephrine…
Headline
As authorized yesterday by the Food and Drug Administration and recommended by its vaccine advisory committee, the Centers for Disease Control and Prevention…
Headline
Under the Department of Health and Human Services’ recent agreement with Regeneron to develop a new monoclonal antibody to prevent COVID-19, the U.S. list…
Headline
In time for back-to-school health screenings, AHA Aug. 25 released an infographic on strategies that clinicians and the Centers for Disease Control and…